Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth

BMC Pregnancy Childbirth. 2017 Jul 26;17(1):246. doi: 10.1186/s12884-017-1427-0.

Abstract

Background: To investigate the utility of vaginal placental alpha microglobulin-1 (PAMG-1) protein as a predictor of preterm delivery within 7 days in pregnancies at risk of premature birth.

Methods: This prospective study was performed in women at risk of premature birth. The levels of vaginal PAMG-1 and foetal fibronectin (fFN) and the transvaginal cervical length measurement (CLM) were investigated and compared.

Results: Seventy-two pregnant women were included in this study. The sensitivities of PAMG-1, fFN and CLM were 73.3, 73.6%, and 52.9%, respectively, while the specificities of PAMG-1, fFN and CLM were 92.9%, 94.3%, and 90.9%, respectively. The positive predictive values of PAMG-1, fFN and CLM were 73.3%, 82.3%, and 64.2%, respectively, and the negative predictive values of PAMG-1, fFN and CLM were 92.9%, 90.9%, and 86.2%, respectively.

Conclusion: The diagnostic accuracy of PAMG-1 is similar to that of fFN in terms of preterm labour detection within 7 days.

Keywords: Fibronectin; PAMG-1; Prematurity; Preterm labour.

MeSH terms

  • Biomarkers / analysis
  • Cervical Length Measurement / nursing*
  • Cervix Uteri / metabolism*
  • Female
  • Fibronectins / analysis*
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 / analysis*
  • Obstetric Labor, Premature / diagnosis*
  • Obstetric Labor, Premature / metabolism
  • Pregnancy
  • Prenatal Care / methods
  • Prospective Studies
  • Risk Factors

Substances

  • Biomarkers
  • FFN protein, human
  • Fibronectins
  • IGFBP1 protein, human
  • Insulin-Like Growth Factor Binding Protein 1